» Articles » PMID: 34100954

Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations

Overview
Journal Endocr Rev
Specialty Endocrinology
Date 2021 Jun 8
PMID 34100954
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The obesity pandemic increasingly causes morbidity and mortality from type 2 diabetes, cardiovascular diseases and many other chronic diseases. Fat cell size (FCS) predicts numerous obesity-related complications such as lipid dysmetabolism, ectopic fat accumulation, insulin resistance, and cardiovascular disorders. Nevertheless, the scarcity of systematic literature reviews on this subject is compounded by the use of different methods by which FCS measurements are determined and reported. In this paper, we provide a systematic review of the current literature on the relationship between adipocyte hypertrophy and obesity-related glucose and lipid dysmetabolism, ectopic fat accumulation, and cardiovascular disorders. We also review the numerous mechanistic origins of adipocyte hypertrophy and its relationship with metabolic dysregulation, including changes in adipogenesis, cell senescence, collagen deposition, systemic inflammation, adipokine secretion, and energy balance. To quantify the effect of different FCS measurement methods, we performed statistical analyses across published data while controlling for body mass index, age, and sex.

Citing Articles

Deep Learning Derived Adipocyte Size Reveals Adipocyte Hypertrophy is under Genetic Control.

Jorsboe E, Kubitz P, Honecker J, Flaccus A, Mvondo D, Raggi M medRxiv. 2025; .

PMID: 39990583 PMC: 11844614. DOI: 10.1101/2025.02.11.25322053.


Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation.

Popa A, Gherasim A, Caba L, Nita O, Graur M, Mihalache L Metabolites. 2024; 14(12).

PMID: 39728453 PMC: 11676726. DOI: 10.3390/metabo14120672.


Eubacterium siraeum suppresses fat deposition via decreasing the tyrosine-mediated PI3K/AKT signaling pathway in high-fat diet-induced obesity.

Lai X, Liu S, Miao J, Shen R, Wang Z, Zhang Z Microbiome. 2024; 12(1):223.

PMID: 39478562 PMC: 11526712. DOI: 10.1186/s40168-024-01944-4.


Targeted Nano-Based Systems for the Anti-Obesity Agent's Delivery.

Engin A, Engin E, Engin A Adv Exp Med Biol. 2024; 1460:657-676.

PMID: 39287868 DOI: 10.1007/978-3-031-63657-8_22.


c-Jun N-terminal kinase signaling in aging.

Li Y, You L, Nepovimova E, Adam V, Heger Z, Jomova K Front Aging Neurosci. 2024; 16:1453710.

PMID: 39267721 PMC: 11390425. DOI: 10.3389/fnagi.2024.1453710.


References
1.
Ravussin E, Tschop M, Morales S, Bouchard C, Heiman M . Plasma ghrelin concentration and energy balance: overfeeding and negative energy balance studies in twins. J Clin Endocrinol Metab. 2001; 86(9):4547-51. DOI: 10.1210/jcem.86.9.8003. View

2.
Marin P, Andersson B, Ottosson M, OLBE L, Chowdhury B, Kvist H . The morphology and metabolism of intraabdominal adipose tissue in men. Metabolism. 1992; 41(11):1242-8. DOI: 10.1016/0026-0495(92)90016-4. View

3.
Dahlman I, Ryden M, Arner P . Family history of diabetes is associated with enhanced adipose lipolysis: Evidence for the implication of epigenetic factors. Diabetes Metab. 2017; 44(2):155-159. DOI: 10.1016/j.diabet.2017.10.010. View

4.
Laforest S, Michaud A, Paris G, Pelletier M, Vidal H, Geloen A . Comparative analysis of three human adipocyte size measurement methods and their relevance for cardiometabolic risk. Obesity (Silver Spring). 2016; 25(1):122-131. DOI: 10.1002/oby.21697. View

5.
McLaughlin T, Craig C, Liu L, Perelman D, Allister C, Spielman D . Adipose Cell Size and Regional Fat Deposition as Predictors of Metabolic Response to Overfeeding in Insulin-Resistant and Insulin-Sensitive Humans. Diabetes. 2016; 65(5):1245-54. PMC: 5384627. DOI: 10.2337/db15-1213. View